Skip to main content
. 2010 May 12;10:246. doi: 10.1186/1471-2458-10-246

Figure 1.

Figure 1

Prevalence of the MS according to WHO, modified ATP III and IDF criteria in all participants and the subjects with each individual metabolic abnormality.